Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

DSLD label record: Liposomal CoQ10 Max capsules by Codeage Amen

This DSLD record lists a Codeage Amen capsule product called Liposomal CoQ10 Max with label-declared vitamin E, coenzyme Q-10 and vitamin E isomers per labelled serving. It is a label snapshot only, not evidence of efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Liposomal CoQ10 MaxOriginal label · NIH DSLD
Liposomal CoQ10 Max

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Servings per container
60
Open original label (PDF)
Ingredients & declared amounts3

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Vitamin E11 mg1 Capsule(s)
Coenzyme Q-10250 mg1 Capsule(s)
Vitamin E Isomers14 mg1 Capsule(s)

Other ingredients: Methylcellulose, Sunflower Oil

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 333417 lists a Codeage Amen capsule product labelled Liposomal CoQ10 Max. [1]

  2. The label declares coenzyme Q-10 at 250 mg per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval or laboratory verification. [1]

The source at a glance

Brand
Codeage Amen
Form
Capsule
Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Ingredients listed
Vitamin E · Coenzyme Q-10 · Vitamin E Isomers
Record type / format
Dietary supplement label/database record
Scope / context
The described product: Liposomal CoQ10 Max capsules by Codeage Amen, not a patient population.
Summary based on
Product label / database record

Codeage Amen capsule listed in DSLD record 333417

The NIH Dietary Supplement Label Database (DSLD) record 333417 describes a product labelled Liposomal CoQ10 Max from the brand Codeage Amen. The label form is a capsule, and the DSLD product category is 'Other Combinations'. The label entered the database on 2025-09-25; the record notes this is not a launch date. The record is a snapshot of label declarations only.

Supporting source [1]

Declared ingredients per labelled serving in this record

The record lists, per labelled serving: vitamin E as D-alpha-tocopherol at 11 mg, coenzyme Q-10 at 250 mg, and vitamin E isomers as beta-tocopherol and delta-tocopherol at 14 mg. These are label facts, not personal dosing advice. The record supplies no independent product testing, price or batch certificate.

Supporting source [1]

What DSLD inclusion does not establish for this product

According to the record, DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record describes label declarations only. It does not rank this product or compare it with others.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. The record describes label declarations only and supplies no independent testing, price or batch certificate.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Liposomal CoQ10 Max

Codeage Amen · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: Liposomal CoQ10 Max
  2. Finding 2 ↑

    Coenzyme Q-10: 250 mg per labelled serving
  3. Finding 3 ↑

    does not establish efficacy, safety, FDA approval

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…